Streptococcus pneumoniae induced p38 MAPK- and NF-κB-dependent COX-2 expression in human lung epithelium

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 290, Issue 6, 2006, Pages

  N'Guessan, Philippe Dje ^a   Hippenstiel, Stefan ^a   Etouem, Mirabelle O ^a   Zahlten, Janine ^a   Beermann, Wiebke ^a   Lindner, David ^a   Opitz, Bastian ^a   Witzenrath, Martin ^a   Rosseau, Simone ^a   Suttorp, Norbert ^a   Schmeck, Bernd ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cyclooxygenase 2; Nuclear factor B; p38 mitogen activated protein kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIAE;

BASE SEQUENCE; CELL LINE; CYCLOOXYGENASE 2; DNA PRIMERS; ENZYME INDUCTION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMIDAZOLES; LUNG; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLASMIDS; PNEUMOCOCCAL INFECTIONS; PYRIDINES; RESPIRATORY MUCOSA; STREPTOCOCCUS PNEUMONIAE; TRANSFECTION;

EID: 33744812706     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00383.2005     Document Type: Article

References (44)

1. Ankermann T, Reisner A, Wiemann T, Krams M, Kohler H, and Krause MF. Topical inhibition of nuclear factor-κB enhances reduction in lung edema by surfactant in a piglet model of airway lavage. Crit Care Med 33: 1384-1391, 2005.
2. Austrian R. The pneumococcus at the millennium: not down, not out. J Infect Dis 179, Suppl 2: S338-S341, 1999.
3. Bowman CC and Bost KL. Cyclooxygenase-2-mediated prostaglandin E2 production in mesenteric lymph nodes and in cultured macrophages and dendritic cells after infection with Salmonella. J Immunol 172: 2469-2475, 2004.
4. Broide DH, Lawrence T, Doherty T, Cho JY, Miller M, McElwain K, McElwain S, and Karin M. Allergen-induced peribronchial fibrosis and mucus production mediated by IκB kinase β-dependent genes in airway epithelium. Proc Natl Acad Sci USA 102: 17723-17728, 2005.
5. Chun KS and Surh YJ. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem Pharmacol 68: 1089-1100, 2004.
6. Finch R. Community-acquired pneumonia: the evolving challenge. Clin Microbiol Infect 7, Suppl 3: 30-38, 2001.
7. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med 78: 32-37, 1985.
8. Hale KK, Trollinger D, Rihanek M, and Manthey CL. Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages. J Immunol 162: 4246-4252, 1999.
9. Harris SG, Padilla J, Koumas L, Ray D, and Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol 23: 144-150, 2002.
10. 2 protects lower airways against bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 290: L105-L113, 2006.
11. Hayden MS and Ghosh S. Signaling to NF-κB. Genes Dev 18: 2195-2224, 2004.
12. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM, Plouffe JF, Rakowsky A, Schuchat A, and Whitney CG. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 160: 1399-1408, 2000.
13. Hippenstiel S, Schmeck B, Seybold J, Krull M, Eichel-Streiber C, and Suttorp N. Reduction of tumor necrosis factor-α (TNF-α) related nuclear factor-κB (NF-κB) translocation but not inhibitor κ-B (Iκ-B)-degradation by Rho protein inhibition in human endothelial cells. Biochem Pharmacol 64: 971-977, 2002.
14. Hippenstiel S, Witzenrath M, Schmeck B, Hocke A, Krisp M, Krull M, Seybold J, Seeger W, Rascher W, Schutte H, and Suttorp N. Adrenomedullin reduces endothelial hyperpermeability. Circ Res 91: 618-625, 2002.
15. Jahn HU, Krull M, Wuppermann FN, Klucken AC, Rosseau S, Seybold J, Hegemann JH, Jantos CA, and Suttorp N. Infection and activation of airway epithelial cells by Chlamydia pneumoniae. J Infect Dis 182: 1678-1687, 2000.
16. Klockmann MT, Jahn HU, Hippenstiel S, Kramer HJ, and Suttorp N. Interaction of human neutrophils with airway epithelial cells: reduction of leukotriene B4 generation by epithelial cell derived prostaglandin E2. J Cell Physiol 175: 268-275, 1998.
17. Knapp S, Wieland CW, van t'Veer C, Takeuchi O, Akira S, Florquin S, and van der Poll CT. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol 172: 3132-3138, 2004.
18. Koch A, Giembycz M, Ito K, Lim S, Jazrawi E, Barnes PJ, Adcock I, Erdmann E, and Chung KF. Mitogen-activated protein kinase modulation of nuclear factor-κB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages. Am J Respir Cell Mol Biol 30: 342-349, 2004.
19. Koedel U, Angele B, Rupprecht T, Wagner H, Roggenkamp A, Pfister HW, and Kirschning CJ. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J Immunol 170: 438-444, 2003.
20. Krull M, Klucken AC, Wuppermann FN, Fuhrmann O, Magerl C, Seybold J, Hippenstiel S, Hegemann JH, Jantos CA, and Suttorp N. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol 162: 4834-4841, 1999.
21. Madrid LV, Mayo MW, Reuther JY, and Baldwin AS Jr. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934-18940, 2001.
22. Manning AM and Davis RJ. Targeting JNK for therapeutic benefit: from junk to gold? Nat Rev Drug Discov 2: 554-565, 2003.
23. May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, and Ghosh S. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science 289: 1550-1554, 2000.
24. Mizumura K, Hashimoto S, Maruoka S, Gon Y, Kitamura N, Matsumoto K, Hayashi S, Shimizu K, and Horie T. Role of mitogen-activated protein kinases in influenza virus induction of prostaglandin E2 from arachidonic acid in bronchial epithelial cells. Clin Exp Allergy 33: 1244-1251, 2003.
25. N'Guessan PD, Schmeck B, Ayim A, Hocke AC, Brell B, Hammerschmidt S, Rosseau S, Suttorp N, and Hippenstiel S. Streptococcus pneumoniae R6x induced p38 MAPK and JNK-mediated caspase-dependent apoptosis in human endothelial cells. Thromb Haemost 94: 295-303, 2005.
26. Nakano H. Signaling crosstalk between NF-κB and JNK. Trends Immunol 25: 402-405, 2004.
27. Opitz B, Puschel A, Schmeck B, Hocke AC, Rosseau S, Hammerschmidt S, Schumann RR, Suttorp N, and Hippenstiel S. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 279: 36426-36432, 2004.
28. Pramanik R, Qi X, Borowicz S, Choubey D, Schultz RM, Han J, and Chen G. p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity. J Biol Chem 278: 4831-4839, 2003.
29. Rahman A, Anwar KN, Minhajuddin M, Bijli KM, Javaid K, True AL, and Malik AB. cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-κB activation and ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 287: L1017-L1024, 2004.
30. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, and Harris CC. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48: 1904-1909, 1988.
31. Richardson JY, Ottolini MG, Pletneva L, Boukhvalova M, Zhang S, Vogel SN, Prince GA, and Blanco JC. Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy. J Immunol 174: 4356-4364, 2005.
32. Saklatvala J. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol 4: 372-377, 2004.
33. Schmeck B, Brunsch M, Seybold J, Krull M, Eichel-Streiber C, Suttorp N, and Hippenstiel S. Rho protein inhibition blocks cyclooxygenase-2 expression by proinflammatory mediators in endothelial cells. Inflammation 27: 89-95, 2003.
34. Schmeck B, Zahlten J, Moog K, van L, V, Huber S, Hocke AC, Opitz B, Hoffmann E, Kracht M, Zerrahn J, Hammerschmidt S, Rosseau S, Suttorp N, and Hippenstiel S. Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor. J Biol Chem 279: 53241-53247, 2004.
35. Seki M, Yanagihara K, Higashiyama Y, Fukuda Y, Kaneko Y, Ohno H, Miyazaki Y, Hirakata Y, Tomono K, Kadota J, Tashiro T, and Kohno S. Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J 24: 143-149, 2004.
36. Song HY, Regnier CH, Kirschning CJ, Goeddel DV, and Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-Jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA 94: 9792-9796, 1997.
37. Strieter RM, Belperio JA, and Keane MP. Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis 16: 193-198, 2003.
38. Tilley SL, Coffman TM, and Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 108: 15-23, 2001.
39. Tiraby JG and Fox MS. Marker discrimination in transformation and mutation of pneumococcus. Proc Natl Acad Sci USA 70: 3541-3545, 1973.
40. Tuomanen EI, Austrian R, and Masure HR. Pathogenesis of pneumococcal infection. N Engl J Med 332: 1280-1284, 1995.
41. Vancheri C, Mastruzzo C, Sortino MA, and Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol 25: 40-46, 2004.
42. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, and Haegeman G. Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22: 1313-1324, 2003.
43. Wang E, Ouellet N, Simard M, Fillion I, Bergeron Y, Beauchamp D, and Bergeron MG. Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice. Infect Immun 69: 5294-5304, 2001.
44. Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, Giri DK, and Hung MC. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6: 251-261, 2004.